Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

Timing of Metastasis in Breast Cancer.

Schwartz RS, Erban JK.

N Engl J Med. 2017 Jun 22;376(25):2486-2488. doi: 10.1056/NEJMcibr1701388. No abstract available.

PMID:
28636861
2.

Neoadjuvant therapy for treatment of breast cancer: the way forward, or simply a convenient option for patients?

Chatterjee A, Erban JK.

Gland Surg. 2017 Feb;6(1):119-124. doi: 10.21037/gs.2016.08.07.

3.

Rapid Change in Mental Status in a Patient with Hypereosinophilia.

Wang H, Erban JK.

Case Rep Hematol. 2017;2017:6936709. doi: 10.1155/2017/6936709. Epub 2017 Jan 10.

4.

Weight Management: Perception, Interest, and Preferences in Adult Cancer Survivors.

Zhang FF, Meagher S, Koch-Weser S, Singer M, Dhaundiyal G, Erban J, Saltzman E.

Clin J Oncol Nurs. 2017 Feb 1;21(1):65-71. doi: 10.1188/17.CJON.65-71.

5.

Promoting High-Quality Cancer Care and Equity Through Disciplinary Diversity in Team Composition.

Parsons SK, Fineberg IC, Lin M, Singer M, Tang M, Erban JK.

J Oncol Pract. 2016 Nov;12(11):1141-1147. Epub 2016 Oct 31.

PMID:
27577618
6.

Adjuvant ovarian suppression in premenopausal breast cancer.

Francis PA, Regan MM, Fleming GF, Láng I, Ciruelos E, Bellet M, Bonnefoi HR, Climent MA, Da Prada GA, Burstein HJ, Martino S, Davidson NE, Geyer CE Jr, Walley BA, Coleman R, Kerbrat P, Buchholz S, Ingle JN, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Colleoni M, Viale G, Coates AS, Goldhirsch A, Gelber RD; SOFT Investigators; International Breast Cancer Study Group.

N Engl J Med. 2015 Jan 29;372(5):436-46. doi: 10.1056/NEJMoa1412379. Epub 2014 Dec 11.

7.

Secondary pulmonary alveolar proteinosis in hematologic malignancies.

Chaulagain CP, Pilichowska M, Brinckerhoff L, Tabba M, Erban JK.

Hematol Oncol Stem Cell Ther. 2014 Dec;7(4):127-35. doi: 10.1016/j.hemonc.2014.09.003. Epub 2014 Oct 6. Review.

8.

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators; International Breast Cancer Study Group.

N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037. Epub 2014 Jun 1.

9.

A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials.

Selker HP, Oye KA, Eichler HG, Stockbridge NL, Mehta CR, Kaitin KI, McElwee NE, Honig PK, Erban JK, D'Agostino RB.

Clin Pharmacol Ther. 2014 Feb;95(2):147-53. doi: 10.1038/clpt.2013.177. Epub 2013 Sep 23.

10.

Invasive breast cancer.

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Zellars R; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Feb;9(2):136-222. No abstract available.

PMID:
21310842
11.

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.

Ganz PA, Land SR, Geyer CE Jr, Cecchini RS, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff JA, Vogel VG, Erban JK, Livingston RB, Perez EA, Mamounas EP, Wolmark N, Swain SM.

J Clin Oncol. 2011 Mar 20;29(9):1110-6. doi: 10.1200/JCO.2010.29.7689. Epub 2011 Feb 7.

12.

Breast cancer: noninvasive and special situations.

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Somlo G, Topham NS, Ward JH, Winer EP, Wolff AC.

J Natl Compr Canc Netw. 2010 Oct;8(10):1182-207. No abstract available.

PMID:
20971842
13.

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.

Swain SM, Jeong JH, Geyer CE Jr, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, Perez EA, Mamounas EP, Land SR, Ganz PA, Wolmark N.

N Engl J Med. 2010 Jun 3;362(22):2053-65. doi: 10.1056/NEJMoa0909638.

14.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators.

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

15.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators.

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
16.

Breast cancer. Clinical practice guidelines in oncology.

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC; NCCN Breast Cancer Clinical Practice Guidelines Panel.

J Natl Compr Canc Netw. 2009 Feb;7(2):122-92. Review. No abstract available.

PMID:
19200416
17.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

18.

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Regan MM, Pagani O, Walley B, Torrisi R, Perez EA, Francis P, Fleming GF, Price KN, Thürlimann B, Maibach R, Castiglione-Gertsch M, Coates AS, Goldhirsch A, Gelber RD; SOFT/TEXT/PERCHE Steering Committee; International Breast Cancer Study Group.

Ann Oncol. 2008 Jul;19(7):1231-41. doi: 10.1093/annonc/mdn037. Epub 2008 Mar 5.

20.

Lack of uniform diagnostic criteria for inflammatory breast cancer limits interpretation of treatment outcomes: a systematic review.

Kim T, Lau J, Erban J.

Clin Breast Cancer. 2006 Dec;7(5):386-95. Review. Erratum in: Clin Breast Cancer. 2008 Feb;8(1):25.

PMID:
17239263

Supplemental Content

Loading ...
Support Center